The increased incidence of chronic conditions among American children predicts serious strains on health care and social welfare systems in the future, caution investigators from Massachusetts General Hospital and Harvard School of Public Health.
Obese diabetes patients may lose weight effectively and decrease their use of glucose-controlling medications with a plate and cereal bowl with markers for proper portion sizes, revealed in a new study.
A new study published on bmj.com questions the value of blood glucose monitoring among patients with well-controlled, non-insulin dependent (type 2) diabetes.
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced study results comparing treatment with BYETTA(R) (exenatide) injection with insulin glargine in people with type 2 diabetes.
Saxagliptin, an inhibitor of dipeptidyl-peptidase-4 (DPP-4) in development by Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN), in combination with metformin, exhibited a statistically significant improvement in glycemic control in subjects with Type 2 diabetes compared to metformin alone through 24 weeks of treatment.
A plate and cereal bowl with markers for proper portion sizes appear to help obese patients with diabetes lose weight and decrease their use of glucose-controlling medications, according to a report in the June 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Novo Nordisk (NYSE:NVO) has announced results of a new study that further demonstrated the safety and efficacy of insulin Levemir? (insulin detemir [rDNA origin] injection).
Galvus (vildagliptin) by Novartis AG (NYSE: NVS), a new once-daily oral treatment for type 2 diabetes submitted for approval in the US and Europe, has been shown in new clinical data to deliver consistent and robust blood sugar reductions in patients with this progressive disease estimated to affect about 246 million people worldwide.
Everyone knows that eating lean fish helps slim waistlines, but researchers from the Center for the Study of Weight Regulation and Associated Disorders at Oregon Health and Science University in Portland, OR, have found a new way fish can help eliminate obesity.
Fifteen top international specialists in this field will gather from 25-27 June for a conference entitled, ?Inflammation and Chronic Disease?, part of the ?Barcelona BioMed? conference series organised by the Institute for Research in Biomedicine (IRB Barcelona) and the Fundaci?n BBVA.